Advertisement
Screener

BLACK DIAMOND THERAPEUTICS, INC. (BDTX) Deferred Tax Assets, Operating Loss Carryforwards

0.7 / 5 stars · 6/46 Roast Me

BLACK DIAMOND THERAPEUTICS, INC. Deferred Tax Assets, Operating Loss Carryforwards

BLACK DIAMOND THERAPEUTICS, INC. (BDTX) had Deferred Tax Assets, Operating Loss Carryforwards of $81.36 million as of 2025-12-31, per its 10-K filed 2026-03-16.

Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross

us-gaap:DeferredTaxAssetsOperatingLossCarryforwards · last filed 2026-03-16

  • 2025-12-31: Deferred Tax Assets, Operating Loss Carryforwards $81.36M.
  • 2024-12-31: Deferred Tax Assets, Operating Loss Carryforwards $78.88M.
  • 2023-12-31: Deferred Tax Assets, Operating Loss Carryforwards $69.19M.
  • 2022-12-31: Deferred Tax Assets, Operating Loss Carryforwards $60.65M.
Period endDeferred Tax Assets, Operating Loss Carryforwards
2025-12-31$81.36M
10-K · filed 2026-03-16
2024-12-31$78.88M
10-K · filed 2026-03-16
2023-12-31$69.19M
10-K · filed 2025-03-06
2022-12-31$60.65M
10-K · filed 2024-03-12
2021-12-31$52.57M
10-K · filed 2023-03-09
2020-12-31$24.06M
10-K · filed 2022-03-17
2019-12-31$9.51M
10-K · filed 2021-03-25
2018-12-31$2.90M
10-K · filed 2020-03-24

Similar stocks

Stock NameCountryMarket CapPE Ratio
Cardiff Oncology, Inc. (CRDF)United States$0.101B-2.22
LENZ Therapeutics, Inc. (LENZ)United States$0.117B-1.41
COGNITION THERAPEUTICS INC (CGTX)United States$0.090B-6.52
enGene Therapeutics Inc. (ENGN)$0.129B-0.92
Pelthos Therapeutics Inc. (PTHS)United States$0.086B-1.20
Atara Biotherapeutics, Inc. (ATRA)United States$0.086B-6.48
Neumora Therapeutics, Inc. (NMRA)United States$0.132B-1.48
Armata Pharmaceuticals, Inc. (ARMP)United States$0.132B
Caribou Biosciences, Inc. (CRBU)United States$0.134B-1.79
Vaxart, Inc. (VXRT)United States$0.080B3.84